What Are GLP-1 Receptor Agonists? How Do They Work?

GLP-1 receptor agonists are a group of medications that mimic the effects of the naturally occurring GLP-1 hormone in the body or create responses similar to these effects. According to the World Health Organization, GLP-1-based therapies are considered among medications that mimic hormone responses related to blood sugar and appetite regulation. GLP-1 is one of the hormones secreted from the intestines after meals and plays an important role in blood sugar balance.

This medication group is especially associated with type 2 diabetes treatment, blood sugar control, appetite regulation, and weight management in some people. The World Health Organization states that GLP-1 therapies are also evaluated in obesity treatment with an approach that considers obesity as a chronic and relapsing disease. However, GLP-1 receptor agonists are not suitable for everyone. The decision to use them should be made based on the person’s health history, existing diseases, blood values, and physician evaluation.

What Does The GLP-1 Hormone Do In The Body?

The GLP-1 hormone is an incretin hormone that helps regulate the body’s blood sugar response after meals. It has effects especially on the pancreas, stomach, intestines, and brain. Therefore, it is associated not only with blood sugar but also with appetite and the feeling of fullness.

The main effects of the GLP-1 hormone can be summarized as follows:

• Supporting Insulin Secretion: It helps increase insulin release from the pancreas when blood sugar rises.
• Reducing Glucagon Secretion: It contributes to limiting excess glucose release from the liver into the blood.
• Slowing Gastric Emptying: It may prolong satiety by reducing the speed at which food passes from the stomach to the intestine.
• Regulating Appetite: It may reduce the desire to eat by acting on appetite centers in the brain.
• Increasing The Feeling Of Fullness: It may help people feel full for a longer time after meals.

How Do GLP-1 Receptor Agonists Work?

GLP-1 receptor agonists bind to GLP-1 receptors in the body and create effects similar to the natural GLP-1 hormone. This mechanism of action becomes more pronounced especially when blood sugar rises. Therefore, this medication group is generally explained with a glucose-dependent mechanism of action.

The working mechanism of GLP-1 receptor agonists can be examined under several main points:

• Effect On The Pancreas: It helps support insulin secretion when blood sugar rises.
• Effect On The Liver: It may reduce glucagon secretion and limit glucose release from the liver into the blood.
• Effect On The Stomach: It may slow gastric emptying and help make post-meal blood sugar increases more balanced.
• Effect On The Brain: It may affect eating behavior through appetite and satiety centers.
• Metabolic Effect: It may play an indirect role in blood sugar balance, weight management, and appetite control processes.

In Which Situations Do GLP-1 Receptor Agonists Come Into Consideration?

GLP-1 receptor agonists most commonly come into consideration in type 2 diabetes treatment and weight management. The World Health Organization states that type 2 diabetes is a chronic disease characterized by high blood sugar, and that healthy nutrition, regular physical activity, weight control, and avoiding tobacco use are important in preventing or delaying type 2 diabetes.

However, this does not mean that the medication is suitable for everyone. The person’s diabetes status, excess weight, accompanying diseases, and other medications used should be evaluated together.

This medication group may come into consideration with physician evaluation in the following situations:

• Type 2 Diabetes: It may be evaluated in people who need support for blood sugar control.
• Weight Management: It may be considered in the weight control process for people who meet certain medical criteria.
• Insulin Resistance: It may come into consideration when metabolic risks are evaluated in some people.
• Cardiometabolic Risks: Risks such as weight, blood sugar, cholesterol, and blood pressure can be examined together.
• Situations Requiring Lifestyle Support: It can be evaluated together with nutrition, movement, and regular follow-up plans.

How Can GLP-1 Receptor Agonists Affect Weight Control?

GLP-1 receptor agonists may affect weight control not through a direct “fat-burning” effect, but rather through appetite, satiety, and gastric emptying. A person may feel full earlier, the duration of satiety after meals may increase, and total calorie intake may decrease.

In its guideline on GLP-1 medicines, the World Health Organization considers obesity as a chronic and relapsing disease and states that GLP-1 therapies can be evaluated in the treatment of obesity in suitable adults. Therefore, weight management should not be considered only with medication but together with long-term health follow-up.

The effects on weight control are generally associated with the following mechanisms:

• Prolonged Satiety: Slower gastric emptying may help people feel full for a longer time.
• Reduced Appetite: The desire to eat may decrease through appetite centers in the brain.
• Reduced Tendency To Snack: Uncontrolled snacking behavior during the day may decrease in some people.
• Easier Portion Control: The feeling of earlier fullness may support portion management.
• Increased Adherence To A Nutrition Plan: It may become easier to follow a nutrition plan prepared with a dietitian.

What Are The Effects On Blood Sugar?

GLP-1 receptor agonists may help especially the post-meal blood sugar response remain more balanced. When blood sugar rises, they may support insulin secretion and reduce glucagon secretion. This mechanism has an important place in type 2 diabetes management.

The World Health Organization states that diabetes can lead to serious consequences for heart, kidney, eye, and vascular health when it is not controlled. Therefore, blood sugar follow-up in the GLP-1 process is important not only for medication use but also for general metabolic health.

The effects on blood sugar can be explained as follows:

• Post-Meal Blood Sugar Control: It may contribute to a more balanced increase in blood sugar after meals.
• Supporting Insulin Response: It may help increase insulin secretion when blood sugar rises.
• Suppression Of Glucagon: It may reduce glucose release from the liver into the blood.
• Contribution To HbA1c Follow-Up: HbA1c value is important in monitoring long-term blood sugar control.
• Need For Metabolic Follow-Up: Blood sugar, kidney functions, and other values should be monitored regularly.

Which Active Ingredients Are Known?

GLP-1 receptor agonists are a broad medication group that includes multiple active ingredients. In this content, providing information only at the level of active ingredients and medication group, without using brand names, is a safer and more professional approach.

In the World Health Organization’s obesity guideline on GLP-1 medicines, active ingredients such as liraglutide, semaglutide, and tirzepatide are addressed in the context of obesity treatment in adults.

Some active ingredients evaluated in this group include:

• Semaglutide: It may come into consideration with physician evaluation in type 2 diabetes and certain weight management processes.
• Liraglutide: It is one of the active ingredients included among GLP-1 receptor agonists.
• Dulaglutide: It is one of the GLP-1 receptor agonists that can be evaluated for blood sugar control.
• Exenatide: It is one of the older active ingredients in this medication group.
• Lixisenatide: It is one of the active ingredients evaluated among GLP-1 receptor agonists.

What Are The Side Effects And Points To Consider?

GLP-1 receptor agonists may cause side effects related to the stomach and intestinal system in some people. Effects such as nausea, vomiting, diarrhea, constipation, stomach discomfort, or decreased appetite may occur. The severity of these symptoms may vary from person to person.

The points to consider are as follows:

• Digestive System Complaints: Complaints such as nausea, vomiting, constipation, or diarrhea may develop.
• Risk Of Fluid Loss: If vomiting or diarrhea occurs, attention should be paid to the risk of fluid loss.
• Blood Sugar Follow-Up: Blood sugar should be monitored more closely when used together with diabetes medications.
• Gallbladder And Pancreas Complaints: Symptoms such as abdominal pain should be taken seriously.
• Personal Suitability: Pregnancy, breastfeeding, chronic diseases, and medications used must be evaluated.

Who Should Not Use Them Without Physician Evaluation?

GLP-1 receptor agonists are medications that require prescription and physician follow-up. Therefore, unconscious use for weight loss purposes may create serious health risks. A decision should not be made without evaluating the person’s blood values, metabolic status, disease history, and medication use.

The World Health Organization emphasizes that GLP-1 therapies should be considered together with lifestyle interventions and regular health follow-up in obesity management. Therefore, the decision to use them should not be made without a personal suitability evaluation.

Groups that require especially careful evaluation include:

• Diabetes Patients: The current treatment plan and blood sugar values should be considered together.
• Pregnant And Breastfeeding People: Medication use during these periods must be evaluated under physician supervision.
• People With A History Of Pancreatic Disease: People who have previously had pancreas-related problems should be evaluated carefully.
• People With Gallbladder Problems: Follow-up may be needed in terms of abdominal pain and digestive complaints.
• People Using Multiple Medications: Medication interactions and general health status should be examined together.

Are GLP-1 Receptor Agonists Enough On Their Own?

GLP-1 receptor agonists may be evaluated as part of the treatment plan in suitable people; however, they do not provide permanent health management on their own. For blood sugar control, weight management, and metabolic health, nutrition, physical activity, sleep routine, and regular follow-up should be considered together.

The World Health Organization emphasizes the importance of healthy nutrition, physical activity, weight control, and avoiding tobacco use in the prevention and management of type 2 diabetes. Therefore, the GLP-1 process should also be evaluated together with physician supervision, lifestyle changes, and regular metabolic follow-up.

Supportive approaches are important in this process:

• Nutrition Plan: It should be planned according to the person’s blood values, weight, and lifestyle.
• Physical Activity: Regular movement supports metabolic health.
• Blood Value Follow-Up: HbA1c, fasting blood glucose, lipid profile, and kidney functions should be monitored.
• Dietitian Support: A sustainable nutrition plan can be created during the weight management process.
• Physician Supervision: Medication use and follow-up frequency must be determined with specialist evaluation.

Evaluate Your GLP-1 Process With An Expert Through Happ Health

GLP-1 receptor agonists are an important medication group related to blood sugar balance, appetite control and weight management. However, the suitability of these medications varies from person to person and the decision to use them should not be made with general information alone.

Happ Health, as a digital health platform, offers a solution that facilitates access to online doctor and check-up processes. You can plan your health process more consciously by getting expert opinion in line with your blood values, weight management goals and diabetes risk.

References

• World Health Organization. “WHO issues global guideline on the use of GLP-1 medicines in treating obesity.” 1 December 2025.
• World Health Organization. “Obesity: GLP-1 therapies.” Questions and answers.
• World Health Organization. “Diabetes.” Fact sheet.